Cite
APA Citation
Foley, J., Defer, G., Ryerson, L. Z., Cohen, J., Arnold, D., Butzkueven, H., Cutter, G., Giovannoni, G., & Killestein, J. (2022). 136 NOVA primary results randomised controlled study of natalizumab Q6W versus continued Q4W treatment for MS. Journal of neurology, neurosurgery and psychiatry, 93(9), e2–. http://access.bl.uk/ark:/81055/vdc_100161680496.0x00005c